Results 21 to 30 of about 10,612 (197)
Case report: Ivabradine induced Torsades de Pointes
IHJ Cardiovascular Case Reports, 2023 Ivabradine is used to control heart rate in patients of heart failure with reduced ejection fraction. Although considered safe, it is reported to prolong QTc interval when given with other QTc prolonging drugs or in setting of hypokalemia or ...
Mohit M. Bhagwati +2 more
doaj +1 more source
The Egyptian Heart Journal, 2018 Introduction: Idiopathic short-coupled ventricular tachyarrhythmias make up a considerable proportion of ventricular tachyarrhythmias in structurally normal hearts and are the cause of 5–10% of unexpected sudden cardiac deaths.
Mohammed Almehairi +2 more
doaj +1 more source
Arquivos Brasileiros de Cardiologia, 2009 Relatamos o caso de uma paciente puérpera, internada com diagnósticos de infecção do trato urinário e insuficiência cardíaca que evoluiu com arritmias ventriculares do tipo torsades de pointes, após hipopotassemia e uso de Ciprofloxacin.
Alexandre Maulaz Barcelos +4 more
doaj +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020 Background The rate of sudden cardiac death in the hemodialysis population exceeds that of the general population by >20‐fold. Hemodialysis patients may be particularly susceptible to sudden cardiac death provoked by drug‐induced QT prolongation because ...
Magdalene M. Assimon +4 more
doaj +1 more source
Acquired Long QT Syndrome and Torsade de Pointes Associated with HIV Infection
Case Reports in Medicine, 2010 Here, we report the case of an HIV infected patient that was treated for pneumonia with a macrolid antibiotic. The patient experienced a prolongation of the already pathologic QTc interval resulting in repeated torsades de pointes necessitating CPR and ...
Alexander Shimabukuro-Vornhagen +7 more
doaj +1 more source
Ticagrelor-Induced Torsades de Pointes following Myocardial Infarction
Case Reports in Cardiology, 2022 We report a case of excessive QT prolongation and subsequent torsades de pointes (TdP) following the administration of ticagrelor in a 58-year-old male patient. The patient had no suspected cause of QT prolongation.
Seong Hyeon Bu, Sung-Hwan Kim
doaj +1 more source
Clinical Cardiology, 1993 AbstractThe polymorphic ventricular tachycardia torsade de pointes can occur in the congenital long QT syndromes or as a consequence of therapy with QT‐prolonging drugs. The latter can include not only antiarrhythmic drugs such as quinidine, but also a number of drugs which are not usually considered to have major cardiovascular effects: these include ...
openaire +2 more sources
“Atrial torsades de pointes” Induced by Low-Energy Shock From Implantable-Cardioverter Defibrillator
Indian Pacing and Electrophysiology Journal, 2013 A 58 year-old-patient developed an episode of polymorphic atrial tachycardia which looked like "atrial torsades de pointes" after a 5J shock from implantable cardioverter defibrillator.
Ilknur Can, MD +1 more
doaj +1 more source
Hypocalcemic torsades de pointes
Journal of Electrocardiology, 1989 Torsades de pointes is a unique form of ventricular tachycardia that occurs in the presence of prolonged QT interval. Many predisposing factors have been identified. A classical form of torsades de pointes occurring in the presence of hypocalcemia and prolonged QT interval in an elderly woman is reported.
T, Akiyama +4 more
openaire +2 more sources
Ondansetron induced torsades de pointes
Clinical Case Reports, 2019 A single dose of oral Ondansetron can precipitate torsades de pointes and other arrhythmias in patients with risk factors that may prolong QTc interval.
Eshan Patel +2 more
doaj +1 more source